explore -WSS

explore

author：Wikipedia 2025-08-26 10:54:36 - browse：347

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Congressmen charge Covid hearing ‘could have been an email’

explore

WSS

Biden administration opens offers in Medicare drug price negotiations

Even great ERs can’t make up for American health disparities

5 important ways Henrietta Lacks changed medical science

‘Oppenheimer’ and the risks of AI in health care

Mega Millions pot grows to $1.25 billion after no winner

Physician groups backed by private equity giant lobby on mergers

hotspot

explore

hotspot

Alkermes shareholders re

Cognito secures funding to test medical device for Alzheimer's

How to save PrEP access — and even expand it

Micronoma's microbiome cancer diagnostic approach under fire

ChatGPT in medicine: STAT answers readers' burning questions

Commercial surrogacy can be ethical, despite pope’s claims

Medical records are filled with copy

Mega Millions pot grows to $1.25 billion after no winner

ChatGPT in medicine: STAT answers readers' burning questions

Commercial surrogacy can be ethical, despite pope’s claims

focus

General Catalyst, Summa Health deal will turn on physician buy

What the airline industry can learn from medicine

Vertex non

Medicare drug price negotiation’s day in court

Sage hopes for a blockbuster in antidepressant now before FDA

Cognito secures funding to test medical device for Alzheimer's

explore

focus

hotspot

explore